Abstract
Ron (the receptor for Macrophage Stimulating Protein) has never been implicated before in human malignancies or in cell transformation. In this report we show that Ron can acquire oncogenic potential by means of two amino acid substitutions–D1232V and M1254T–affecting highly conserved residues in the tyrosine kinase domain. The same mutations in Kit and Ret have been found associated with two human malignancies, mastocytosis and Multiple Endocrine Neoplasia type 2B (MEN2B), respectively. Both mutations caused Ron-mediated transformation of 3T3 fibroblasts and tumour formation in nude mice. Moreover, cells transformed by the oncogenic Ron mutants displayed high metastatic potential. The Ron mutant receptors were constitutively active and the catalytic efficiency of the mutated kinase was higher than that of wild-type Ron. Oncogenic Ron mutants enhanced activation of the Ras/MAPK cascade with respect to wild type Ron, without affecting the JNK/SAPK pathway. Expression of Ron mutants in 3T3 fibroblasts led to different patterns of tyrosine-phosphorylated proteins. These data show that point mutations altering catalytic properties and possibly substrate specificity of the Ron kinase may force cells toward tumorigenesis and metastasis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Santoro, M., Penengo, L., Minetto, M. et al. Point mutations in the tyrosine kinase domain release the oncogenic and metastatic potential of the ron receptor. Oncogene 17, 741–749 (1998). https://doi.org/10.1038/sj.onc.1201994
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1201994
Keywords
This article is cited by
-
Elevated RON protein expression in endometriosis and disease-associated ovarian cancers
Archives of Gynecology and Obstetrics (2017)
-
Strategies of targeting the extracellular domain of RON tyrosine kinase receptor for cancer therapy and drug delivery
Journal of Cancer Research and Clinical Oncology (2016)
-
Molecular mechanisms that underpin EML4-ALK driven cancers and their response to targeted drugs
Cellular and Molecular Life Sciences (2016)
-
Variant RONΔ160 of the RON receptor tyrosine kinase promotes the growth and invasion in vitro and in vivo in gastric cancer cell lines
Cancer Cell International (2015)
-
MSP–RON signalling in cancer: pathogenesis and therapeutic potential
Nature Reviews Cancer (2013)